Publications.

  • Fernandez Gonzalez De La Vega C, Duenweg S, Jain P, Rubenstein SI, Bobholz S, Barrett MJ, LaViolette PS, Iczkowski KA. Morphologic features of prostate cancer-encased native vessels: An image analysis study. Pathol Res Pract. 2024 Apr;256:155239. doi: 10.1016/j.prp.2024.155239. Epub 2024 Mar 6. PMID: 38461692.

  • Bobholz SA, Lowman AK, Connelly JM, Duenweg SR, Winiarz A, Nath B, Kyereme F, Brehler M, Bukowy J, Coss D, Lupo JM, Phillips JJ, Ellingson BM, Krucoff MO, Mueller WM, Banerjee A, LaViolette PS. Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast Enhancement. Neurosurgery. 2024 Mar 19. doi: 10.1227/neu.0000000000002898. Epub ahead of print. PMID: 38501824.

  • Bobholz SA, Hoefs A, Hamburger J, Lowman AK, Winiarz A, Duenweg SR, Kyereme F, Connelly J, Coss D, Krucoff M, Banerjee A, LaViolette PS. Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response. J Neurooncol. 2024 Apr;167(2):233-241. doi: 10.1007/s11060-024-04593-7. Epub 2024 Feb 19. Erratum in: J Neurooncol. 2024 Apr;167(2):243. doi: 10.1007/s11060-024-04641-2. PMID: 38372901; PMCID: PMC11024025.

  • Shalom ES, Kim H, van der Heijden RA, Ahmed Z, Patel R, Hormuth DA 2nd, DiCarlo JC, Yankeelov TE, Sisco NJ, Dortch RD, Stokes AM, Inglese M, Grech-Sollars M, Toschi N, Sahoo P, Singh A, Verma SK, Rathore DK, Kazerouni AS, Partridge SC, LoCastro E, Paudyal R, Wolansky IA, Shukla-Dave A, Schouten P, Gurney-Champion OJ, Jiřík R, Macíček O, Bartoš M, Vitouš J, Das AB, Kim SG, Bokacheva L, Mikheev A, Rusinek H, Berks M, Hubbard Cristinacce PL, Little RA, Cheung S, O'Connor JPB, Parker GJM, Moloney B, LaViolette PS, Bobholz S, Duenweg S, Virostko J, Laue HO, Sung K, Nabavizadeh A, Saligheh Rad H, Hu LS, Sourbron S, Bell LC, Fathi Kazerooni A. The ISMRM Open Science Initiative for Perfusion Imaging (OSIPI): Results from the OSIPI-Dynamic Contrast-Enhanced challenge. Magn Reson Med. 2024 May;91(5):1803-1821. doi: 10.1002/mrm.29909. Epub 2023 Dec 19. PMID: 38115695.

2024

  • Duenweg SR, Brehler M, Lowman AK, Bobholz SA, Kyereme F, Winiarz A, Nath B, Iczkowski KA, Jacobsohn KM, LaViolette PS. Quantitative Histomorphometric Features of Prostate Cancer Predict Patients Who Biochemically Recur Following Prostatectomy. Lab Invest. 2023 Dec;103(12):100269. doi: 10.1016/j.labinv.2023.100269. Epub 2023 Oct 26. PMID: 37898290; PMCID: PMC10872376.

  • Duenweg SR, Bobholz SA, Barrett MJ, Lowman AK, Winiarz A, Nath B, Stebbins M, Bukowy J, Iczkowski KA, Jacobsohn KM, Vincent-Sheldon S, LaViolette PS. T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. Cancers (Basel). 2023 Sep 6;15(18):4437. doi: 10.3390/cancers15184437. PMID: 37760407; PMCID: PMC10526331.

  • Duenweg SR, Bobholz SA, Lowman AK, Stebbins MA, Winiarz A, Nath B, Kyereme F, Iczkowski KA, LaViolette PS. Whole slide imaging (WSI) scanner differences influence optical and computed properties of digitized prostate cancer histology. J Pathol Inform. 2023 Jul 4;14:100321. doi: 10.1016/j.jpi.2023.100321. PMID: 37496560; PMCID: PMC10365953.

  • Duenweg SR, Brehler M, Bobholz SA, Lowman AK, Winiarz A, Kyereme F, Nencka A, Iczkowski KA, LaViolette PS. Comparison of a machine and deep learning model for automated tumor annotation on digitized whole slide prostate cancer histology. PLoS One. 2023 Mar 16;18(3):e0278084. doi: 10.1371/journal.pone.0278084. PMID: 36928230; PMCID: PMC10019669.

2023

  • Ruchti A, Neuwirth A, Lowman AK, Duenweg SR, LaViolette PS, Bukowy JD. Homologous point transformer for multi-modality prostate image registration. PeerJ Comput Sci. 2022 Dec 1;8:e1155. doi: 10.7717/peerj-cs.1155 PMID: 36532813; PMCID: PMC9748842.

  • Duenweg SR, Fang X, Bobholz SA, Lowman AK, Brehler M, Kyereme F, Iczkowski KA, Jacobsohn KM, Banerjee A, LaViolette PS. Diffusion Restriction Comparison between Gleason 4 Fused Glands and Cribriform Glands within Patient Using Whole-Mount Prostate Pathology as Ground Truth. Tomography. 2022 Mar 2;8(2):635-643. doi: 10.3390/tomography8020053. PMID: 35314630; PMCID: PMC8938782.

  • Bobholz SA, Lowman AK, Brehler M, Kyereme F, Duenweg SR, Sherman J, McGarry SD, Cochran EJ, Connelly J, Mueller WM, Agarwal M, Banerjee A, LaViolette PS. Radio-Pathomic Maps of Cell Density Identify Brain Tumor Invasion beyond Traditional MRI-Defined Margins. AJNR Am J Neuroradiol. 2022 May;43(5):682-688. doi: 10.3174/ajnr.A7477. Epub 2022 Apr 14. PMID: 35422419; PMCID: PMC9089258.

2022

  • McGarry SD, Brehler M, Bukowy JD, Lowman AK, Bobholz SA, Duenweg SR, Banerjee A, Hurrell SL, Malyarenko D, Chenevert TL, Cao Y, Li Y, You D, Fedorov A, Bell LC, Quarles CC, Prah MA, Schmainda KM, Taouli B, LoCastro E, Mazaheri Y, Shukla-Dave A, Yankeelov TE, Hormuth DA 2nd, Madhuranthakam AJ, Hulsey K, Li K, Huang W, Huang W, Muzi M, Jacobs MA, Solaiyappan M, Hectors S, Antic T, Paner GP, Palangmonthip W, Jacobsohn K, Hohenwalter M, Duvnjak P, Griffin M, See W, Nevalainen MT, Iczkowski KA, LaViolette PS. Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness. J Magn Reson Imaging. 2022 Jun;55(6):1745-1758. doi: 10.1002/jmri.27983. Epub 2021 Nov 12. PMID: 34767682; PMCID: PMC9095769.

  • Brehler M, Lowman AK, Bobholz SA, McGarry SD, Connelly J, Cochran E, LaViolette PS. Quantitative Analysis of Alzheimer’s Disease Pathology in Glioblastoma Patients. Proc. SPIE 11603, Medical Imaging 2021: Digital Pathology. 2021 Feb 15. doi: 10.1117/12.2580725.

2021

  • Bukowy JD, Foss H, McGarry SD, Lowman AK, Hurrell SL, Iczkowski KA, Banerjee A, Bobholz SA, Barrington A, Dayton A, Unteriner J, Jacobsohn K, See WA, Nevalainen MT, Nencka AS, Ethridge T, Jarrard DF, LaViolette PS. Accurate segmentation of prostate cancer histomorphometric features using a weakly supervised convolutional neural network. J Med Imaging (Bellingham). 2020 Sep;7(5):057501. doi: 10.1117/1.JMI.7.5.057501. Epub 2020 Oct 13. PMID: 33062803; PMCID: PMC7550797.

  • McGarry SD, Bukowy JD, Iczkowski KA, Lowman AK, Brehler M, Bobholz S, Nencka A, Barrington A, Jacobsohn K, Unteriner J, Duvnjak P, Griffin M, Hohenwalter M, Keuter T, Huang W, Antic T, Paner G, Palangmonthip W, Banerjee A, LaViolette PS. Radio-pathomic mapping model generated using annotations from five pathologists reliably distinguishes high-grade prostate cancer. J Med Imaging (Bellingham). 2020 Sep;7(5):054501. doi: 10.1117/1.JMI.7.5.054501. Epub 2020 Sep 9. PMID: 32923510; PMCID: PMC7479263.

  • Palangmonthip W, Wu R, Tarima S, Bobholz SA, LaViolette PS, Gallan AJ, Iczkowski KA. Corpora amylacea in benign prostatic acini are associated with concurrent, predominantly low-grade cancer. Prostate. 2020 Jun;80(9):687-697. doi: 10.1002/pros.23980. Epub 2020 Apr 9. PMID: 32271960; PMCID: PMC10561550.

  • Bobholz SA, Lowman AK, Barrington A, Brehler M, McGarry S, Cochran EJ, Connelly J, Mueller WM, Agarwal M, O'Neill D, Nencka AS, Banerjee A, LaViolette PS. Radiomic Features of Multiparametric MRI Present Stable Associations With Analogous Histological Features in Patients With Brain Cancer. Tomography. 2020 Jun;6(2):160-169. doi: 10.18383/j.tom.2019.00029. PMID: 32548292; PMCID: PMC7289245.

2020

  • Bukowy JD, Foss H, McGarry SD, Lowman AK, Hurrell SL, Iczkowski KA, Banerjee A, Bobholz SA, Barrington A, Dayton A, Unteriner J, Jacobsohn K, See WA, Nevalainen MT, Nencka AS, Ethridge T, Jarrard DF, LaViolette PS. Accurate segmentation of prostate cancer histomorphometric features using a weakly supervised convolutional neural network. J Med Imaging (Bellingham). 2020 Sep;7(5):057501. doi: 10.1117/1.JMI.7.5.057501. Epub 2020 Oct 13. PMID: 33062803; PMCID: PMC7550797.

  • McGarry SD, Bukowy JD, Iczkowski KA, Lowman AK, Brehler M, Bobholz S, Nencka A, Barrington A, Jacobsohn K, Unteriner J, Duvnjak P, Griffin M, Hohenwalter M, Keuter T, Huang W, Antic T, Paner G, Palangmonthip W, Banerjee A, LaViolette PS. Radio-pathomic mapping model generated using annotations from five pathologists reliably distinguishes high-grade prostate cancer. J Med Imaging (Bellingham). 2020 Sep;7(5):054501. doi: 10.1117/1.JMI.7.5.054501. Epub 2020 Sep 9. PMID: 32923510; PMCID: PMC7479263.

  • Palangmonthip W, Wu R, Tarima S, Bobholz SA, LaViolette PS, Gallan AJ, Iczkowski KA. Corpora amylacea in benign prostatic acini are associated with concurrent, predominantly low-grade cancer. Prostate. 2020 Jun;80(9):687-697. doi: 10.1002/pros.23980. Epub 2020 Apr 9. PMID: 32271960; PMCID: PMC10561550.

  • Bobholz SA, Lowman AK, Barrington A, Brehler M, McGarry S, Cochran EJ, Connelly J, Mueller WM, Agarwal M, O'Neill D, Nencka AS, Banerjee A, LaViolette PS. Radiomic Features of Multiparametric MRI Present Stable Associations With Analogous Histological Features in Patients With Brain Cancer. Tomography. 2020 Jun;6(2):160-169. doi: 10.18383/j.tom.2019.00029. PMID: 32548292; PMCID: PMC7289245

  • McGarry SD, Bukowy JD, Iczkowski KA, Unteriner JG, Duvnjak P, Lowman AK, Jacobsohn K, Hohenwalter M, Griffin MO, Barrington AW, Foss HE, Keuter T, Hurrell SL, See WA, Nevalainen MT, Banerjee A, LaViolette PS. Gleason Probability Maps: A Radiomics Tool for Mapping Prostate Cancer Likelihood in MRI Space. Tomography. 2019 Mar;5(1):127-134. doi: 10.18383/j.tom.2018.00033. PMID: 30854450; PMCID: PMC6403022.

2019

  • McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS. Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1179-1187. doi: 10.1016/j.ijrobp.2018.04.044. Epub 2018 Apr 24. PMID: 29908785; PMCID: PMC6190585.

  • Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS. Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging. J Med Imaging (Bellingham). 2018 Jan;5(1):011004. doi: 10.1117/1.JMI.5.1.011004. Epub 2017 Oct 27. PMID: 29098169; PMCID: PMC5658575.

2018

  • McGarry SD, Hurrell SL, Kaczmarowski AL, Cochran EJ, Connelly J, Rand SD, Schmainda KM, LaViolette PS. Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy. Tomography. 2016 Sep;2(3):223-228. doi: 10.18383/j.tom.2016.00250. PMID: 27774518; PMCID: PMC5074084.

  • Nguyen HS, Milbach N, Hurrell SL, Cochran E, Connelly J, Bovi JA, Schultz CJ, Mueller WM, Rand SD, Schmainda KM, LaViolette PS. Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma. AJNR Am J Neuroradiol. 2016 Dec;37(12):2201-2208. doi: 10.3174/ajnr.A4898. Epub 2016 Aug 4. PMID: 27492073; PMCID: PMC5161572.

2016

  • Mickevicius NJ, Carle AB, Bluemel T, Santarriaga S, Schloemer F, Shumate D, Connelly J, Schmainda KM, LaViolette PS. Location of brain tumor intersecting white matter tracts predicts patient prognosis. J Neurooncol. 2015 Nov;125(2):393-400. doi: 10.1007/s11060-015-1928-5. Epub 2015 Sep 16. PMID: 26376654; PMCID: PMC6094943.

2015